(Q46789035)

25 December 2017

title

Monitoring of clopidogrel-related platelet inhibition: correlation of nonresponse with clinical outcome in supra-aortic stenting (English)

1 reference

25 December 2017

1 reference

2

1 reference

25 December 2017

author name string

S Müller-Schunk

1

1 reference

25 December 2017

N Peters

3

1 reference

25 December 2017

M Spannagl

4

1 reference

25 December 2017

M Deisenberg

5

1 reference

25 December 2017

H Brückmann

6

1 reference

25 December 2017

T E Mayer

7

1 reference

25 December 2017

publication date

25 January 2008

1 reference

25 December 2017

American Journal of Neuroradiology

published in

1 reference

25 December 2017

volume

29

1 reference

25 December 2017

issue

4

1 reference

25 December 2017

page(s)

786-791

1 reference

25 December 2017

Determinants of the interindividual variability in response to antiplatelet drugs

cites work

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A0917

Individual variations of platelet inhibition after loading doses of clopidogrel

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A0917

Clopidogrel for coronary stenting: response variability, drug resistance, and the effect of pretreatment platelet reactivity

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A0917

Variability in platelet responsiveness to clopidogrel among 544 individuals.

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A0917

High clopidogrel loading dose during coronary stenting: effects on drug response and interindividual variability.

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A0917

Prasugrel achieves greater inhibition of platelet aggregation and a lower rate of non-responders compared with clopidogrel in aspirin-treated patients with stable coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A0917

The relation of dosing to clopidogrel responsiveness and the incidence of high post-treatment platelet aggregation in patients undergoing coronary stenting

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A0917

Resistance to clopidogrel: a review of the evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A0917

Lack of association between the P2Y12 receptor gene polymorphism and platelet response to clopidogrel in patients with coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A0917

High post-treatment platelet reactivity identified low-responders to dual antiplatelet therapy at increased risk of recurrent cardiovascular events after stenting for acute coronary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A0917

Clopidogrel resistance: implications for coronary stenting

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A0917

Combined aspirin and clopidogrel resistance associated with recurrent coronary stent thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A0917

Platelet reactivity in patients and recurrent events post-stenting: results of the PREPARE POST-STENTING Study

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A0917

US multicenter experience with the wingspan stent system for the treatment of intracranial atheromatous disease: periprocedural results.

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A0917

Monitoring platelet inhibition after clopidogrel with the VerifyNow-P2Y12(R) rapid analyzer: the VERIfy Thrombosis risk ASsessment (VERITAS) study

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A0917

The platelet inhibiting effect of a clopidogrel bolus dose in patients on long-term acetylsalicylic acid treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A0917

Monitoring of clopidogrel action: comparison of methods

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A0917

Determination of clopidogrel resistance by whole blood platelet aggregometry and inhibitors of the P2Y12 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A0917

30 day results from the SPACE trial of stent-protected angioplasty versus carotid endarterectomy in symptomatic patients: a randomised non-inferiority trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A0917

Endarterectomy versus stenting in patients with symptomatic severe carotid stenosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A0917

Stenting of symptomatic M1 stenosis of middle cerebral artery: an initial experience of 40 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A0917

Stenting of Symptomatic Atherosclerotic Lesions in the Vertebral or Intracranial Arteries (SSYLVIA): study results.

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A0917

The benefits of combined anti-platelet treatment in carotid artery stenting

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A0917

Effects of clopidogrel and aspirin in combination versus aspirin alone on platelet activation and major receptor expression in patients after recent ischemic stroke: for the Plavix Use for Treatment of Stroke (PLUTO-Stroke) trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A0917

Enhanced antiplatelet effect of clopidogrel in patients whose platelets are least inhibited by aspirin: a randomized crossover trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A0917

Impact of the degree of peri-interventional platelet inhibition after loading with clopidogrel on early clinical outcome of elective coronary stent placement.

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A0917

Low response to clopidogrel is associated with cardiovascular outcome after coronary stent implantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A0917

Suspected clopidogrel resistance in a patient with acute stent thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A0917

Clinical, biochemical and genetical resistance to clopidogrel in a patient with the recurrent coronary stent thrombosis--a case report and review of the literature.

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A0917

Stent thrombosis is associated with an impaired response to antiplatelet therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A0917

Flow cytometric analysis of intraplatelet VASP phosphorylation for the detection of clopidogrel resistance in patients with ischemic cardiovascular diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A0917

Clopidogrel resistance is associated with increased risk of recurrent atherothrombotic events in patients with acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A0917

Response to aspirin and clopidogrel in patients scheduled to undergo cardiovascular surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A0917

Onset and extent of platelet inhibition by clopidogrel loading in patients undergoing elective coronary stenting: the Plavix Reduction Of New Thrombus Occurrence (PRONTO) trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A0917

Effect of a high loading dose of clopidogrel on platelet function in patients undergoing coronary stent placement

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A0917

Single high-dose bolus tirofiban with high-loading-dose clopidogrel in primary coronary angioplasty

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A0917

Aspirin resistance:a new independent predictor of vascular events?**Editorials published in the Journal of the American College of Cardiologyreflect the views of the authors and do no necessarily represent the views of JACCor the American College of

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A0917

21 January 2018

Identifiers

DOI

10.3174/AJNR.A0917

1 reference

25 December 2017

release_st2et63jcjhvfaydyvc47fnbjq

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/st2et63jcjhvfaydyvc47fnbjq

mapped directly with Wikidata item

24 November 2022

based on heuristic

PubMed ID

18223094

1 reference

25 December 2017